
Dec 31, 2025 02:05 am UTC| Business Technology
Elon Musk announced on Tuesday that his artificial intelligence startup, xAI, has acquired a third building to further expand its computing infrastructure, signaling a major step in the companys effort to compete with...

Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Dec 31, 2025 02:03 am UTC| Business
Lockheed Martin has strengthened its position as a leading global defense contractor after securing multiple U.S. Department of Defense and allied military contracts collectively valued at nearly $500 million. These awards...

Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Dec 31, 2025 01:53 am UTC| Business
Nike Inc. (NYSE: NKE) shares moved higher in after-hours trading on Tuesday, gaining approximately 1.6% after the company disclosed a significant insider stock purchase by its chief executive officer, Elliott Hill. The...

Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Dec 31, 2025 01:51 am UTC| Business Health
Novo Nordisk and Eli Lilly are significantly lowering prices of their blockbuster obesity drugs Wegovy and Mounjaro in China, a move aimed at expanding access in one of the worlds fastest-growing weight-loss markets and...

ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Dec 31, 2025 01:49 am UTC| Business Technology
Chinas technology giant ByteDance is preparing to significantly ramp up its artificial intelligence investment, with plans to spend about 100 billion yuan (approximately $14 billion) on AI chips in 2026, according to a...

Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Dec 31, 2025 01:47 am UTC| Governance Business Health
Vanda Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for its drug tradipitant, branded as Nereus, marking the first new FDA-approved treatment for motion-induced vomiting in more...

Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Dec 30, 2025 10:50 am UTC| Business Health
Novo Nordisk and Eli Lilly are reducing prices for their widely used obesity medications, Wegovy and Mounjaro, in China, a move that could significantly expand patient access in one of the worlds largest pharmaceutical...